08/02/2019 19:58:27

CLASS ACTION UPDATE for IMMU, AGN, MAXR and MU: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

NEW YORK, Feb. 08, 2019 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court and further details about the cases can be found at the links provided. There is no cost or obligation to you.

Immunomedics, Inc. (NASDAQ: IMMU)

Class Period: August 23, 2018 - December 20, 2018

Lead Plaintiff Deadline: February 25, 2019

Join the action: https://www.zlk.com/pslra-1/immunomedics-inc-loss-form?wire=3

The complaint alleges that, throughout the class period, defendants made false and misleading statements. The United States Food & Drug Administration issued citations against Immunomedics for multiple violations at its Morris Plains, New Jersey facility. The FDA citations included the manipulation of bioburden samples, backdating of records, and misrepresentation of integrity test procedures. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. On December 17, 2018, FDAnews.com published an article entitled “FDA Hits Immunomedics for Data Integrity Breach.” Upon this news, Immunomedics’ stock price fell sharply, damaging investors.

To learn more about the Immunomedics, Inc. class action contact jlevi@levikorsinsky.com.

Allergan plc (NYSE: AGN)

Class Period: February 24, 2017 - December 19, 2018

Lead Plaintiff Deadline: February 19, 2019

Join the action: https://www.zlk.com/pslra-1/allergan-plc-loss-form?wire=3

Allegations: Allergan plc made materially false and/or misleading statements and/or failed to disclose that: (i) textured breast implants manufactured by Allergan were linked to ALCL; (ii) the foregoing link to cancer, when revealed, would foreseeably force Allergan to recall those textured breast implants from the market; and (iii) as a result, the Company’s public statements were materially false and misleading at all relevant times.

To learn more about the Allergan plc class action contact jlevi@levikorsinsky.com.

Maxar Technologies Inc. (NYSE: MAXR)

Class Period: March 29, 2018 - January 7, 2019

Lead Plaintiff Deadline: March 15, 2019

Join the action: https://www.zlk.com/pslra-1/maxar-technologies-inc-loss-form?wire=3

Allegations: During the class period, Maxar Technologies Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) Maxar improperly inflated the value of its intangible assets, among other accounting improprieties; (ii) Maxar’s highly-valued WorldView-4 was equipped with CMGs that were faulty and/or ill-suited for their designed and intended purpose; and (iii) as a result, Maxar’s public statements were materially false and misleading at all relevant times.

To learn more about the Maxar Technologies Inc. class action contact jlevi@levikorsinsky.com.

Micron Technology Inc. (NASDAQGS: MU)

Class Period: September 26, 2017 - November 19, 2018

Lead Plaintiff Deadline: March 25, 2019

Join the action: https://www.zlk.com/pslra-1/micron-technology-inc-loss-form?wire=3

Allegations: Micron Technology Inc. made materially false and/or misleading statements throughout the class period and/or failed to disclose that: (1) the Company engaged in anti-competitive behavior, including artificially restricting supply growth of DRAM; (2) these anti-competitive efforts were reasonably likely to lead to regulatory scrutiny; (3) the Company’s anti-competitive efforts artificially boosted its operating metrics; (4) as a result, the Company’s financial performance, including revenue, was overstated; and (5) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

To learn more about the Micron Technology Inc. class action contact jlevi@levikorsinsky.com.

You have until the lead plaintiff deadlines to request the court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Toll Free: (877) 363-5972

Fax: (212) 363-7171

www.zlk.com

250x148_zlk.jpg

Related content
15 Aug - 
Micron Commences Volume Production of 1z Nanometer DRAM..
15 Aug - 
Micron Unveils Industry’s Highest-Capacity Monolithic M..
07 Aug - 
Immunomedics Reports Second Quarter 2019 Results and Pr..
Del

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
Ingen indlæg

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
Photo Release -- WSFS Bank Welcomes Corynn Ciber in Newly Created Role, Chief Digital Officer
2
TTM Technologies, Inc. Announces Executive Transition
3
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Eagle Bancorp, Karyopharm, L Brands, and National General and Encourages Investors to Contact the Firm
4
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Mallinckrodt, Oasmia Pharmaceutical, Aclaris Therapeutics, and Curaleaf and Encourages Investors to Contact the Firm
5
Hagens Berman Investigating SAExploration Holdings (SAEX): Earnings Restatements, SEC Investigation, and Senior Executives Fired

Related stock quotes

Micron Technology Inc 45.01 3.4% Stock price increasing
Immunomedics Inc 14.84 -0.7% Stock price decreasing
Allergan PLC Ordinary Sh.. 159.25 0.6% Stock price increasing

Latest news


Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
20 August 2019 00:29:35
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190819.1 - EUROWEB1 - 2019-08-20 01:29:35 - 2019-08-20 00:29:35 - 1000 - Website: OKAY